The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
95490403 9549040 3 F 201401 20160809 20130924 20160816 EXP CA-ROCHE-1279888 ROCHE 67.75 YR M Y 70.70000 KG 20160816 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
95490403 9549040 1 PS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) DAY 1 AND DAY 15 103705 1000 MG SOLUTION FOR INFUSION
95490403 9549040 2 SS RITUXAN RITUXIMAB 1 103705
95490403 9549040 3 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Unknown 50722
95490403 9549040 4 C DIPHENHYDRAMINE HCL DIPHENHYDRAMINE HYDROCHLORIDE 1 Oral 0 50 MG
95490403 9549040 5 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 0 650 MG
95490403 9549040 6 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 0 100 MG
95490403 9549040 7 C PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 0
95490403 9549040 8 C PREDNISONE. PREDNISONE 1 Oral ALTERNATING DAYS 0
95490403 9549040 9 C PREDNISONE. PREDNISONE 1 Oral ALTERNATING DAYS?CURRENT DOSE 10MG/DAY 0
95490403 9549040 10 C NORVASC AMLODIPINE BESYLATE 1 0
95490403 9549040 11 C ZESTRIL LISINOPRIL 1 0
95490403 9549040 12 C ACTONEL RISEDRONATE SODIUM 1 Unknown 0 /month
95490403 9549040 13 C MINOCYCLINE MINOCYCLINEMINOCYCLINE HYDROCHLORIDE 1 0
95490403 9549040 14 C ASPIRIN. ASPIRIN 1 Unknown ALTERNATING DAYS 0 81 MG
95490403 9549040 15 C VITAMIN C ASCORBIC ACID 1 0
95490403 9549040 16 C GLUTEN DIET 2 0
95490403 9549040 17 C GINKOBA GINKGO 1 0
95490403 9549040 18 C IVIG HUMAN IMMUNOGLOBULIN G 1 Unknown 0 /month
95490403 9549040 19 C POTASSIUM CITRATE. POTASSIUM CITRATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
95490403 9549040 1 Sjogren's syndrome
95490403 9549040 2 Autoimmune encephalopathy
95490403 9549040 3 Product used for unknown indication
95490403 9549040 4 Premedication
95490403 9549040 5 Premedication
95490403 9549040 6 Premedication

Outcome of event

Event ID CASEID OUTC COD
95490403 9549040 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
95490403 9549040 Anastomotic ulcer
95490403 9549040 Diarrhoea
95490403 9549040 Encephalopathy
95490403 9549040 Eye infection viral
95490403 9549040 Fatigue
95490403 9549040 Glucose tolerance impaired
95490403 9549040 Off label use
95490403 9549040 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
95490403 9549040 1 20130430 0
95490403 9549040 4 20130430 0
95490403 9549040 5 20130430 0
95490403 9549040 6 20130430 0